EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL‐2 in Breast Cancer

Wei Wang, Jun Liu iD, Yun Wei iD, Yan Fang, Shuning Ding, Deyue Liu, Li Zhu iD

The Breast Journal · 2026-01 · 2026 (1)

DOI: 10.1155/tbj/5295439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast Journal, online erschienen am 22.07.2026. Verfasst von Wei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai 200080, China,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Interleukin-2, Interleukin-2 Receptor alpha Subunit. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Medical Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is a leading female malignancy, with chronic inflammation driving progression. The IL‐2/IL‐2R axis regulates immunity, but IL2RA’s role in breast cancer (expression, diagnostic/prognostic value, and interplay with IL‐2) is unclear.

Methods

A total of 252 consecutive patients (99 breast cancer and 153 benign breast disease) who received breast surgery were retrospectively analyzed. Serum cytokines were measured via electrochemiluminescence immunoassay; ROC, single‐cell sequencing, and bioinformatics databases (TIMER and Kaplan–Meier plotter) were used to assess IL2RA/IL‐2’s utility and associations.

Results

Serum IL2Rα was higher in breast cancer (336.9 vs. 275.8 U/mL, p < 0.001; no significant differences were observed for other cytokines). IL2Rα showed moderate diagnostic performance (AUC = 0.650, cut‐off = 240.5 U/mL), correlated with NLR ( p = 0.012), and showed a trend towards poor survival ( p = 0.124, HR = 0.309, 95% CI: 0.069–1.381). Single‐cell sequencing identified T cells as the primary source of IL2Rα in tumor tissues. High IL2RA expression strongly correlated with infiltration of immune cells, especially neutrophils ( r = 0.673) and dendritic cells ( r = 0.706). RNA‐seq analysis showed IL2RA was upregulated in tumor tissues, associated with poor prognosis ( p = 9.7 e − 06, HR = 1.29, 95% CI: 1.15–1.44) and aggressive features (e.g., lymph node metastasis and HER2 positivity). In contrast, IL‐2 was highly expressed in normal tissues, linked to better prognosis ( p = 0.001, HR = 0.83, 95% CI: 0.74–0.93), and had opposing clinical correlations.

Conclusions

Serum IL2Rɑ could serve as a complementary auxiliary diagnostic biomarker for breast cancer, with associations with systemic inflammation, immune cell infiltration, and aggressive disease. The functional antagonism between IL2RA and IL‐2 highlights the IL‐2/IL2RA axis as a critical regulator of breast cancer pathophysiology, supporting its potential as a therapeutic target for improving breast cancer diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorInterleukin-2Interleukin-2 Receptor alpha SubunitHumansFemaleMiddle AgedRetrospective StudiesPrognosisAgedAdult

Stichwörter der Autor:innen

IL2Rαbiomarkerbreast cancercytokinesimmune infiltration

Substanzen

Biomarkers, TumorInterleukin-2Interleukin-2 Receptor alpha SubunitIL2RA protein, humanIL2 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai 200080, China, shsmu.edu.cn.
  • Department of Nursing, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai 200080, China, shsmu.edu.cn.

ORCID-Profile: Jun Liu, Yun Wei, Li Zhu

Förderung

  • Beijing Medical Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Wang, W., Liu, J., Wei, Y., Fang, Y., Ding, S., Liu, D., & Zhu, L. (2026). Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL‐2 in Breast Cancer. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/5295439

Vancouver

Wang W, Liu J, Wei Y, Fang Y, Ding S, Liu D, et al. Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL‐2 in Breast Cancer. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/5295439

BibTeX
@article{Wang2026,
  author = {Wang, Wei and Liu, Jun and Wei, Yun and Fang, Yan and Ding, Shuning and Liu, Deyue and Zhu, Li},
  title = {Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL‐2 in Breast Cancer},
  journal = {The Breast Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbj/5295439}
}
Kostenlos starten →